Roberta Murru

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 10

Top Topics

Ejection Fraction

End Stage Renal Disease

Patient Reported

Chronic Lymphocytic Leukemia

Top Venues

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology 103 (5) (2024)
Andrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, Roberta Murru, Roberto Marasca
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents. Cancers 16 (11) (2024)
Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology 103 (5) (2024)
Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology 103 (5) (2024)
Francesca Romana Mauro, Potito Rosario Scalzulli, Lydia Scarfò, Carla Minoia, Roberta Murru, Paolo Sportoletti, Ferdinando Frigeri, Francesco Albano, Nicola Di Renzo, Alessandro Sanna, Luca Laurenti, Massimo Massaia, Ramona Cassin, Marta Coscia, Caterina Patti, Elsa Pennese, Agostino Tafuri, Annalisa Chiarenza, Piero Galieni, Omar Perbellini, Carmine Selleri, Catello Califano, Felicetto Ferrara, Antonio Cuneo, Marco Murineddu, Gaetano Palumbo, Ilaria Scortechini, Alessandra Tedeschi, Livio Trentin, Marzia Varettoni, Fabrizio Pane, Anna Marina Liberati, Francesco Merli, Lucia Morello, Gerardo Musuraca, Monica Tani, Adalberto Ibatici, Giulia Regazzoni, Michele Di Candia, Maria Palma, Danilo Arienti, Stefano Molica
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study. Cancers 16 (6) (2024)
Francesca Romana Mauro, Potito Rosario Scalzulli, Lydia Scarfò, Carla Minoia, Roberta Murru, Paolo Sportoletti, Ferdinando Frigeri, Francesco Albano, Nicola Di Renzo, Alessandro Sanna, Luca Laurenti, Massimo Massaia, Ramona Cassin, Marta Coscia, Caterina Patti, Elsa Pennese, Agostino Tafuri, Annalisa Chiarenza, Piero Galieni, Omar Perbellini, Carmine Selleri, Catello Califano, Felicetto Ferrara, Antonio Cuneo, Marco Murineddu, Gaetano Palumbo, Ilaria Scortechini, Alessandra Tedeschi, Livio Trentin, Marzia Varettoni, Fabrizio Pane, Anna Marina Liberati, Francesco Merli, Lucia Morello, Gerardo Musuraca, Monica Tani, Adalberto Ibatici, Giulia Regazzoni, Michele Di Candia, Maria Palma, Danilo Arienti, Stefano Molica
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study. Cancers 16 (6) (2024)
Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology (2024)
Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology 103 (5) (2024)
Andrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, Roberta Murru, Roberto Marasca
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents. Cancers 16 (11) (2024)
Roberta Murru, Andrea Galitzia, Luca Barabino, Roberta Presicci, Giorgio La Nasa, Giovanni Caocci
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of hematology 103 (5) (2024)